These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MARATHON BAR CORP
.
|
|
(Exact name of Registrant as specified in its charter)
|
|
Delaware
|
99-0370688
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
427 N Tatnall Street
Wilmington DE
|
19801-2230
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
+ 1 888 267-1134
|
|
(Registrant’s telephone number, including area code)
|
|
N/A
|
N/A
|
|
|
Title of each class
|
Name of each exchange on which registered
|
|
Shares of Common Stock, $0.0001 par value
|
|
Title of Class
|
| Large accelerated filer | o | Accelerated filer | o |
| Non-accelerated filer | o | Smaller reporting company | þ |
|
PART I
|
|||||
|
Item 1.
|
Business
|
4 | |||
|
Item 1A
|
Risk Factors
|
8 | |||
|
Item 2.
|
Properties
|
11 | |||
|
Item 3.
|
Legal Proceedings
|
11 | |||
|
Item 4.
|
Mine Safety Disclosures
|
11 | |||
|
PART II
|
|||||
|
Item 5.
|
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
|
12 | |||
|
Item 6.
|
Selected Financial Data
|
12 | |||
|
Item 7.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
13 | |||
|
Item 7A.
|
Quantitative and Qualitative Disclosures About Market Risk
|
14 | |||
|
Item 8.
|
Financial Statements and Supplementary Data
|
F-1 | |||
|
Item 9.
|
Changes In and Disagreements With Accountants on Accounting and Financial Disclosure
|
15 | |||
|
Item 9A.
|
Controls and Procedures
|
15 | |||
|
Item 9B.
|
Other Information
|
15 | |||
|
PART III
|
|||||
|
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
16 | |||
|
Item 11.
|
Executive Compensation
|
17 | |||
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
18 | |||
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence.
|
19 | |||
|
Item 14.
|
Principal Accounting Fees and Services
|
19 | |||
|
PART IV
|
|||||
|
Item 15.
|
Exhibits, Financial Statement Schedules
|
21
|
|||
|
SIGNATURES
|
22 | ||||
|
·
|
risks related to our ability to continue as a going concern;
|
|
·
|
the uncertainty of profitability based upon our history of losses;
|
|
·
|
risks related to failure to obtain adequate financing on a timely basis and on acceptable terms for our planned development projects;
|
|
·
|
risks related to our ability to continue to fund research and development costs;
|
|
·
|
risks related to conducting business internationally due to our operations in Israel;
|
|
·
|
risks related to our ability to successfully develop our technology into commercial products,
|
|
·
|
risks related to our ability to successfully prosecute and protect our intellectual property;
|
|
·
|
risks related to tax assessments;
and
|
|
·
|
other risks and uncertainties related to our prospects, properties, and business strategy.
|
|
ITEM 1.
|
BUSINESS
|
|
o
|
at local sporting events,
|
|
|
o
|
through health stores;
|
|
|
o
|
and over our website:
|
|
o
|
Forums for the users of our product that are open to all endurance athletes and not driven by specific teams or clubs
|
|
|
o
|
Updates as to which events will be sponsored by us as well as tips for such event
|
|
|
o
|
Comparisons among different products even if these products are distributed by competitors
|
|
ITEM 1A.
|
RISK FACTORS
|
|
ITEM 2.
|
PROPERTIES
|
|
ITEM 3.
|
LEGAL PROCEEDINGS
|
|
ITEM 4.
|
MINE SAFETY DISCLOSURES
|
|
ITEM 5.
|
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
|
|
ITEM 6.
|
SELECTED FINANCIAL DATA
|
|
ITEM 7.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
ITEM 7A.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
|
ITEM 8.
|
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
|
|
Report of Registered Independent Auditors
|
F-2 |
|
Financial Statements-
|
||||
|
Balance Sheets as of December 31, 2012 and 2011
|
F-3 | |||
|
Statements of Operations for the Years Ended December 31, 2012 and 2011, and Cumulative from Inception
|
F-4 | |||
|
Statement of Stockholders’ Equity for the Period from Inception
through December 31, 2012
|
F-5 | |||
|
Statements of Cash Flows for the Years Ended December 31, 2012 and 2011, and Cumulative from Inception
|
F-6 | |||
|
Notes to Financial Statements
|
F-7 | |||
| /s/ Weinberg & Baer LLC | |
|
As of
|
As of
|
|||||||
|
December 31,
|
December 31,
|
|||||||
|
2012
|
2011
|
|||||||
|
Current Assets:
|
||||||||
|
Cash or cash equivalents
|
$ | 577 | $ | 22,943 | ||||
|
Deferred offering costs
|
- | 9,500 | ||||||
|
Total current assets
|
577 | 32,443 | ||||||
|
Total Assets
|
$ | 577 | $ | 32,443 | ||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
Current Liabilities:
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 11,655 | $ | 7,367 | ||||
|
Due to shareholders
|
238 | 238 | ||||||
|
Total Current Liabilities
|
11,893 | 7,605 | ||||||
|
Commitments and Contingencies
|
- | - | ||||||
|
Stockholders' Equity (Deficit):
|
||||||||
|
Common stock, par value $0.0001 per share, 100,000,000 shares authorized;
|
||||||||
|
3,500,000 and 3,000,000 shares issued and outstanding respectively
|
350 | 300 | ||||||
|
Additional paid-in capital
|
70,150 | 29,700 | ||||||
|
(Deficit) accumulated during development stage
|
(81,816 | ) | (5,162 | ) | ||||
|
Total stockholders' equity (deficit)
|
(11,316 | ) | 24,838 | |||||
|
Total Liabilities and Stockholders' Equity
|
$ | 577 | $ | 32,443 | ||||
|
Year Ended
|
Year Ended
|
Cumulative
|
|||||||||||
|
December, 31
|
December, 31
|
From
|
|||||||||||
|
2012
|
2011
|
Inception
|
|||||||||||
|
Revenues
|
$ | - | $ | - | $ | - | |||||||
|
Expenses:
|
|||||||||||||
|
General and administrative -
|
|||||||||||||
|
Filing fee
|
5,958 | 1,391 | 7,349 | ||||||||||
|
Professional fees
|
35,792 | 2,738 | 38,530 | ||||||||||
|
Consulting fees
|
33,975 | - | 33,975 | ||||||||||
|
Incorporation
|
- | 867 | 867 | ||||||||||
|
Franchise tax expense
|
400 | - | 400 | ||||||||||
|
Other
|
529 | 166 | 695 | ||||||||||
|
Total general and administrative expenses
|
76,654 | 5,162 | 81,816 | ||||||||||
| - | - | - | |||||||||||
|
(Loss) from Operations
|
(76,654 | ) | (5,162 | ) | (81,816 | ) | |||||||
|
Provision for income taxes
|
- | - | - | ||||||||||
|
Net (Loss)
|
$ | (76,654 | ) | $ | (5,162 | ) | $ | (81,816 | ) | ||||
|
(Loss) Per Common Share:
|
|||||||||||||
|
(Loss) per common share - Basic and Diluted
|
$ | (0.02 | ) | $ | - | ||||||||
| Weighted Average Number of Common Shares Outstanding - Basic and Diluted | 3,374,317 | 1,800,000 | |||||||||||
|
(Deficit)
|
||||||||||||||||||||
|
Accumulated
|
||||||||||||||||||||
|
Additional
|
During the
|
|||||||||||||||||||
|
Common stock
|
Paid-in
|
Development
|
||||||||||||||||||
|
Description
|
Shares
|
Amount
|
Capital
|
Stage
|
Totals
|
|||||||||||||||
|
Balance - at inception
|
- | $ | - | $ | - | $ | - | $ | - | |||||||||||
|
Common stock issued for cash ($0.01/share)
|
3,000,000 | 300 | 29,700 | - | 30,000 | |||||||||||||||
|
Net (loss) for the period
|
- | - | - | (5,162 | ) | (5,162 | ) | |||||||||||||
|
Balance - December 31, 2011
|
3,000,000 | 300 | 29,700 | (5,162 | ) | 24,838 | ||||||||||||||
|
Common stock issued for cash ($0.1/share)
|
500,000 | 50 | 40,450 | - | 40,500 | |||||||||||||||
|
Net (loss) for the period
|
- | - | - | (76,654 | ) | (76,654 | ) | |||||||||||||
|
Balance - December 31, 2012
|
3,500,000 | $ | 350 | $ | 70,150 | $ | (81,816 | ) | $ | (11,316 | ) | |||||||||
| Year Ended | Year Ended |
Cumulative
|
||||||||||
| December 31, | December 31, |
From
|
||||||||||
|
2012
|
2011
|
Inception
|
||||||||||
|
Operating Activities:
|
||||||||||||
|
Net (loss)
|
$ | (76,654 | ) | $ | (5,162 | ) | $ | (81,816 | ) | |||
|
Adjustments to reconcile net (loss) to net cash
|
||||||||||||
|
provided by operating activities:
|
||||||||||||
|
Deferred offering costs
|
9,500 | (9,500 | ) | - | ||||||||
|
Accounts payable and accrued liabilities
|
4,288 | 7,367 | 11,655 | |||||||||
|
Net Cash Used in Operating Activities
|
(62,866 | ) | (7,295 | ) | (70,161 | ) | ||||||
|
Investing Activities:
|
||||||||||||
|
Cash provided by investing activities
|
- | - | - | |||||||||
|
Net Cash Provided by Investing Activities
|
- | - | - | |||||||||
|
Financing Activities:
|
||||||||||||
|
Due to shareholders
|
- | 238 | 238 | |||||||||
|
Proceeds from common stock
|
40,500 | 30,000 | 70,500 | |||||||||
|
Net Cash Provided by Financing Activities
|
40,500 | 30,238 | 70,738 | |||||||||
|
Net (Decrease) Increase in Cash
|
(22,366 | ) | 22,943 | 577 | ||||||||
|
Cash - Beginning of Period
|
22,943 | - | - | |||||||||
|
Cash - End of Period
|
$ | 577 | $ | 22,943 | $ | 577 | ||||||
|
Supplemental Disclosure of Cash Flow Information:
|
||||||||||||
|
Cash paid during the period for:
|
||||||||||||
|
Interest
|
$ | - | $ | - | $ | - | ||||||
|
Income taxes
|
$ | - | $ | - | $ | - | ||||||
|
2012
|
2011
|
|||||||
|
Current Tax Provision:
|
||||||||
|
Federal-
|
||||||||
|
Taxable income
|
$ | - | $ | - | ||||
|
Total current tax provision
|
$ | - | $ | - | ||||
|
Deferred Tax Provision:
|
||||||||
|
Federal-
|
||||||||
|
Loss carryforwards
|
$ | 11,498 | $ | 774 | ||||
|
Change in valuation allowance
|
(11,498 | ) | (774 | ) | ||||
|
Total deferred tax provision
|
$ | - | $ | - | ||||
|
2012
|
2011
|
|||||||
|
Loss carryforwards
|
$ | 12,272 | $ | 774 | ||||
|
Less - Valuation allowance
|
(12,272 | ) | (774 | ) | ||||
|
Total net deferred tax assets
|
$ | - | $ | - | ||||
|
ITEM 9.
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
|
|
ITEM 9A.
|
CONTROLS AND PROCEDURES
|
|
ITEM 9B.
|
OTHER INFORMATION
|
|
ITEM 10.
|
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
|
Name
|
Age
|
Position
|
||
|
Mr. Israel MenahemVizel
|
34
|
President, Secretary/ Treasurer, Chief Financial
Officer, Chief Executive Officer and Chairman of
the Board of Directors.
|
|
ITEM 11.
|
EXECUTIVE COMPENSATION
|
|
ITEM 12.
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
|
|
Name and Address
of Beneficial
Owner
(²)
|
Position
|
Amount and
Nature
of Beneficial
Ownership
|
Percentage of
Class(¹)
|
|||||||||
|
Common Stock
|
Israel MenahemVizel
|
CEO, President,Treasurer, Secretary and Director
|
3,000,000
|
86
|
%
|
|||||||
|
All Directors and officers as a Group
|
3,000,000
|
86 | % | |||||||||
|
(¹)
|
Based on 3,500,000 shares of our common stock outstanding.
|
|
(²)
|
The address for Mr. Vizel is at 45 Bait Vegan Street Jerusalem.
|
|
Plan category
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights
(a)
|
Weighted-average exercise price of outstanding options, warrants and rights
(b)
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
(c)
|
|||||||||
|
Equity compensation plans approved by security holders
|
0 | 0 | 0 | |||||||||
|
Equity compensation plans not approved by security holders
|
0 | 0 | 0 | |||||||||
|
Total
|
0 | 0 | 0 | |||||||||
|
ITEM 13.
|
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.
|
|
·
|
any Director or officer of our Company;
|
|
·
|
any proposed Director of officer of our Company;
|
|
·
|
any person who beneficially owns, directly or indirectly, shares carrying more than 5 percent of the voting rights attached to our common stock; or
|
|
·
|
any member of the immediate family of any of the foregoing persons (including a spouse, parents, children, siblings, and in-laws).
|
|
ITEM 14.
|
PRINCIPAL ACCOUNTING FEES AND SERVICES
|
|
December 31,
2012
(1)
|
December 31,
2011
(1)
|
|||||||
|
Audit Fees
|
$ | 10,500 | $ | 2,500 | ||||
|
Audit Related Fees
|
0 | 0 | ||||||
|
Tax Fees
|
250 | 250 | ||||||
|
All Other Fees
|
0 | 0 | ||||||
|
(1)
|
For the years ended December 31, 2012 and December 31, 2011, principal accountants of the Company were Weinberg & Baer LLC.
|
|
ITEM 15.
|
EXHIBITS, FINANCIAL STATEMENT SCHEDULES
|
|
(a)
|
Financial Statements and financial statement schedules
|
|
(b)
|
Exhibits required by Item 601 of Regulation S-K
|
|
Exhibit No.
|
Description
|
|
|
3.1
|
Certificate of Incorporation (incorporated by reference from our Registration Statement on Form S-1).
|
|
|
3.2
|
Bylaws (incorporated by reference from our Registration Statement on Form S-1).
|
|
|
31*
|
Section 302 Certification of the Sarbanes-Oxley Act of 2002 of Israel MenahemVizel
|
|
|
32*
|
Section 302 Certification of the Sarbanes-Oxley Act of 2002 of Israel MenahemVizel
|
|
101.INS **
|
XBRL Instance Document
|
|
|
101.SCH **
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL **
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.DEF **
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB **
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
101.PRE **
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
MARATHON BAR CORP
.
(Registrant)
|
|||
|
Dated: February 26, 2013
|
By:
|
/s/ Israel MenahemVizel | |
| Name: | Israel MenahemVizel | ||
| Title: |
President, Chief Executive and Financial Officer
|
||
| (Principal Executive and Financial Officer), Secretary and Director | |||
|
Dated: February 26, 2013
|
By:
|
/s/
Israel MenahemVizel
|
|
| Name: |
Israel MenahemVizel
|
||
| Title: |
President, Chief Executive and Treasurer
|
||
| (Principal Executive and Financial Officer), Secretary and Director |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|